General information about company

Scrip code530207
NSE Symbol
MSEI Symbol
ISIN*INE899B01015
Name of companyBRAWN BIOTECH LIMITED
Class of securityEquity
Date of start of financial year01-04-2017
Date of end of financial year31-03-2018
Date of board meeting when results were approved29-05-2018
Date on which prior intimation of the meeting for considering financial results was informed to the exchange22-05-2018
Description of presentation currencyINR
Level of rounding used in financial resultsLakhs
Reporting QuarterYearly
Nature of report standalone or consolidatedStandalone
Whether results are audited or unauditedAudited
Segment ReportingSingle segment
Description of single segmentPharmaceuticals
Start time of board meeting15:30
End time of board meeting17:00



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
ADate of start of reporting period01-01-201801-04-2017
BDate of end of reporting period31-03-201831-03-2018
CWhether results are audited or unauditedAuditedAudited
DNature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations1570.515578.37
Other income25.528.97
Total income1596.035587.34
2Expenses
(a)Cost of materials consumed00
(b)Purchases of stock-in-trade1390.754882.19
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade8.242.46
(d)Employee benefit expense 83.43298.19
(e)Finance costs1.635.73
(f)Depreciation, depletion and amortisation expense0.783.16
(f)Other Expenses
1Breakage & Expiry10.9114.66
2Administration Cost2.2311.33
3Communication Cost1.426.01
4Corporate Travel Cost17.4948.47
5Legal & Professional Cost0.723.49
6Material Manufacturing & Consumption Cost1.742.82
7Sales & Marketing Cost23.9258.81
8Supply & Services Cost9.4636.11
9Scrap Expenses01.1
10Misc. Expenses11.8916.7
Total other expenses79.78199.5
Total expenses1564.615391.23

Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
ADate of start of reporting period01-01-201801-04-2017
BDate of end of reporting period31-03-201831-03-2018
CWhether results are audited or unauditedAuditedAudited
DNature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3Total profit before exceptional items and tax31.42196.11
4Exceptional items 00
5Total profit before tax31.42196.11
7Tax expense
8Current tax16.8871.22
9Deferred tax-1.56-3.28
10Total tax expenses15.3267.94
11Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
14Net Profit Loss for the period from continuing operations16.1128.17
15Profit (loss) from discontinued operations before tax00
16Tax expense of discontinued operations00
17Net profit (loss) from discontinued operation after tax00
19Share of profit (loss) of associates and joint ventures accounted for using equity method00
21Total profit (loss) for period16.1128.17
22Other comprehensive income net of taxes0.91-2.74

Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
ADate of start of reporting period01-01-201801-04-2017
BDate of end of reporting period31-03-201831-03-2018
CWhether results are audited or unauditedAuditedAudited
DNature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23Total Comprehensive Income for the period17.01125.43
24Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
25Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent00
Total comprehensive income for the period attributable to owners of parent non-controlling interests00
26Details of equity share capital
Paid-up equity share capital300.03300.03
Face value of equity share capital1010
27Details of debt securities
Paid-up debt capital00
Face value of debt securities00
28Reserves excluding revaluation reserve463.06
29Debenture redemption reserve
30Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations0.574.18
Diluted earnings (loss) per share from continuing operations0.574.18
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiEarnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations0.574.18
Diluted earnings (loss) per share from continuing and discontinued operations0.574.18
31Debt equity ratio
32Debt service coverage ratio
33Interest service coverage ratio
34Disclosure of notes on financial resultsTextual Information(1)

Text Block

Textual Information(1)1. Results for the quarter and year ended 31st March, 2018 were reviewed by the Audit Committee and then approved by the Board of Directors at their meeting held on 29.05.2018.

2. The above results have been prpared in compliance with the recognition and measurement principles of the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS), as amended by the Companies (Indian Accounting Standards) (Amendment rules), 2016 prescribed under Section133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. Beginning 1st April, 2017, the Company has for the first time adopted Ind AS with Transition date of 1st April, 2016.

3. The Statutory Auditors carried out the Audit for the year ended on 31st March, 2018. The management has exercised necessary due diligence to ensure that the financial results provided a true and fair view of its affairs.

4. The Company is engaged primarily in the business of Pharmaceuticals. Accordingly, there is no separate reportable segments as per Ind- AS 108 dealing with Operating Segments.

5. The above Standalone Audited Financial Results for the Quarter and year ended 31.03.2018 are available on Company's website www.brawnbiotech.com and BSE website www.bseindia.com.

6. Reconciliation of the net profit as per previous Indian GAAP and Ind AS for the quarter ended 31st March, 2018:

Sr. No. Description Sub Notes Quarter ended Year ended 30th
31st March, 2018 31st March, 2018
Net Profit as per previous Indian GAAP 23.16 139.30
1 Fair Valuation adjustments for financial assets (i) - -
2 Actuarial loss on employee defined
benefits plan recognised in OCI (ii) - -0.05
3 Deferred Tax impact on Ind AS adjustments (iii) - -
Net Profit as per Ind AS 23.16 139.25


Sub Notes:

(i) Under Indian GAAP, current Investments were measured at lower of cost and net realisable value. Under Ind AS, financial assets other than those valued at amortised cost are subsequently measured at fair value.
(ii) Under Indian GAAP, re-measurement gain/loss on defined benefits plans is charged to the Statement of Profit and Loss. Under Ind AS, such re-measurement gain/loss is reported as an item that will not be reclassified to profit or loss under the Statement of other Comprehensive Income (OCI).
(iii) Under India GAAP, deferred taxes are recognised using Income statement approach i.e. reflecting the tax effects of timing differences between accounting income and taxable income for the period. The impact of transition adjustments together with Ind AS mandate of using balance sheet approach (against income approach under Indian GAAP) for computation of deferred tax has resulted in consequential impact to Statement of Profit and Loss.

7. Previous year / period figures have been regrouped / rearranged, wherever necessary to make them comparable with the current period figures.



Statement of Asset and Liabilities

ParticularsCurrent year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2017
Date of end of reporting period31-03-2018
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone
Assets
1 Non-current assets
Property, plant and equipment22.28
Capital work-in-progress0
Investment property0
Goodwill0
Other intangible assets0
Intangible assets under development0
Biological assets other than bearer plants0
Investments accounted for using equity method0
Non-current financial assets
Non-current investments0
Trade receivables, non-current47.66
Loans, non-current3.14
Other non-current financial assets0
Total non-current financial assets50.8
Deferred tax assets (net)8
Other non-current assets0
Total non-current assets81.08
2Current assets
Inventories34.76
Current financial asset
Current investments0
Trade receivables, current1505.42
Cash and cash equivalents39.61
Bank balance other than cash and cash equivalents0
Loans, current0
Other current financial assets473.85
Total current financial assets2018.88
Current tax assets (net)109.86
Other current assets12.65
Total current assets2176.15

Statement of Asset and Liabilities

ParticularsCurrent year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2017
Date of end of reporting period31-03-2018
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone
3Non-current assets classified as held for sale0
4Regulatory deferral account debit balances and related deferred tax Assets0
Total assets2257.23
Equity and liabilities
Equity
Equity attributable to owners of parent
Equity share capital300.03
Other equity463.07
Total equity attributable to owners of parent763.1
Non controlling interest
Total equity763.1
Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current0
Trade payables, non-current3.32
Other non-current financial liabilities0
Total non-current financial liabilities3.32
Provisions, non-current0
Deferred tax liabilities (net)16.73
Deferred government grants, Non-current0
Other non-current liabilities0
Total non-current liabilities20.05
Current liabilities
Current financial liabilities
Borrowings, current0
Trade payables, current1122.85
Other current financial liabilities112.78
Total current financial liabilities1235.63
Other current liabilities83.16
Provisions, current43.95
Current tax liabilities (Net)111.34
Deferred government grants, Current
Total current liabilities1474.08
3Liabilities directly associated with assets in disposal group classified as held for sale
4Regulatory deferral account credit balances and related deferred tax liability
Total liabilities1494.13
Total equity and liabilites2257.23
Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars3 months/ 6 month ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-01-201801-04-2017
Date of end of reporting period31-03-201831-03-2018
Whether accounts are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedStandaloneStandalone
1Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3(Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments